Inventor · disambiguated record
Christian Dombrowski
Also filed as: DOMBROWSKI CHRISTIAN
9 granted patents·11 pending applications·6 citations·filing 2009–2025
79Inventor score
Files withINTELLIA THERAPEUTICS INC12AGENCY SCIENCE TECH & RES4COOL SIMON MCKENZIE2DOMBROWSKI CHRISTIAN1R3—RELIABLE REALTIME RADIO COMMUNICATIONS GMBH1
Top patents by PatentIndex Score
20 records- 0188US11673911B2Stabilized nucleic acids encoding messenger ribonucleic acid (mRNA)INTELLIA THERAPEUTICS INC·Filed 2020·Granted Jun 13, 2023·2 cites·22 claims
- 0280US12391722B2Stabilized nucleic acids encoding messenger ribonucleic acid (mRNA)INTELLIA THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·23 claims
- 0379US2025346625A1Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA)INTELLIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0476US11697806B2Polynucleotides, compositions, and methods for genome editingINTELLIA THERAPEUTICS INC·Filed 2020·Granted Jul 11, 2023·1 cites·26 claims
- 0574US9498494B2GlycosaminoglycansCOOL SIMON MCKENZIE·Filed 2012·Granted Nov 22, 2016·3 cites·21 claims
- 0667US2025276090A1Methods and Compositions for Genetically Modifying a CellINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0765US10086044B2Heparan sulphate which binds BMP2COOL SIMON MCKENZIE·Filed 2009·Granted Oct 2, 2018·0 cites·19 claims
- 0865US2024002820A1Polynucleotides, Compositions, and Methods for Genome Editing Involving DeaminationINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0964US2024076636A1Polynucleotides, Compositions, and Methods for Genome EditingINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1064US2011159071A1Isolation and Identification of GlycosaminoglycansAGENCY SCIENCE TECH & RES·Filed 2009·Application pending·0 cites
- 1162US2025302874A1Cd38 compositions and methods for immunotherapyINTELLIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1260US10220054B2GlycosaminoglycansAGENCY SCIENCE TECH & RES·Filed 2016·Granted Mar 5, 2019·0 cites·15 claims
- 1359US2018360916A1Isolation and Identification of GlycosaminoglycansAGENCY SCIENCE TECH & RES·Filed 2018·Application pending·0 cites
- 1456US10245301B2GlycosaminoglycansAGENCY SCIENCE TECH & RES·Filed 2016·Granted Apr 2, 2019·0 cites·14 claims
- 1552US2025375537A1Systems and Methods for Genomic EditingINTELLIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1652US2023012687A1Polynucleotides, Compositions, and Methods for Polypeptide ExpressionINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1742US2019136231A1Lipid nanoparticle formulations for crispr/cas componentsINTELLIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1841US2018112234A9Methods and compositions for gene editingINTELLIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1937US12120663B2Method of operating a communication systemR3—RELIABLE REALTIME RADIO COMMUNICATIONS GMBH·Filed 2020·Granted Oct 15, 2024·0 cites·14 claims
- 2033US9344249B2Method for a transmitter for a multi-channel communication system for sending real-time dataDOMBROWSKI CHRISTIAN·Filed 2012·Granted May 17, 2016·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Christian Dombrowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →